Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention

Eur J Prev Cardiol. 2020 Dec;27(19):2338-2340. doi: 10.1177/2047487319894103. Epub 2019 Dec 16.

Authors

Alberto Somaschini^{1

2}, Stefano Cornara^{1

2}, Andrea Demarchi^{1

2}, Alessandro Mandurino-Mirizzi^{1

2}, Federico Fortuni^{1

2}, Gabriele Crimi³, Marco Ferlini³, Rita Camporotondo¹, Massimiliano Gnecchi^{1

2}, Luigi Oltrona Visconti³, Gaetano M De Ferrari⁴

Affiliations

¹ Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology - Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
² Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Pavia, Italy.
³ Division of Cardiology - Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
⁴ Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Italy.

PMID: 31841054
DOI: 10.1177/2047487319894103

No abstract available

MeSH terms

Aged
Biomarkers / blood
Female
Humans
Italy
Male
Middle Aged
Neutrophils*
Percutaneous Coronary Intervention*
Platelet Count*
Prognosis
Prospective Studies
ST Elevation Myocardial Infarction / mortality
ST Elevation Myocardial Infarction / surgery*
Survival Rate

Substances

Biomarkers